Innovating Works

ENERGESA

Activa
ADVOS-COVID-19: Increasing Survival of Patients with Severe SARS CoV 2 Infection and or Multi Organ Failure by up to... ENERGESA participó en un H2020: H2020-EIC-SMEInst-2018-2020 ADVITOS` innovation – the ADVOS therapy system - has the potential to increase the survival of COVID-19 patients suffering from severe multi...
2020-07-27 - 2023-06-30 | Financiado
MITODYN: Role of calcium fluxes in mitochondrial dynamics ENERGESA participó en un H2020: H2020-MSCA-IF-2016 Mitochondria house hundreds of biochemical reactions involved in processes critical for the survival and homeostatic adaptation of the cell....
2017-03-29 - 2019-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.